By: Priyanka Meta Date: January 11, 2024 Priyanka Meta, a meteorology consultant associated with the University Hospitals of Bristol and…
Browsing: Other
In the realm of advancements in CAR T-cell therapy for relapsed/refractory mantle cell lymphoma (MCL), Dr. Brian Hill, MD, PhD,…
In this ASH 2023 interview, Dr. Jos Melenhorst discusses a collaborative study on single-cell multi-omics in pediatric ALL patients. The…
At ASH 2023, Katherine Broome, MD, a medical doctor and medical oncologist at the Georgetown Lombardi Comprehensive Cancer Center at…
By. Valeria Santini, MDDate: 12/13/2023At the ASH 2023 symposium, Valeria Santini, MD, a distinguished medical doctor and associate professor of…
By. Saranya Chumsri, MD Date: 12/12/2023 Saranya Chumsri, MD, an expert in the field of triple-negative breast cancer (TNBC), will…
At ASH 2023, there is a discussion with Dr. Davide Matino, Assistant Professor of Medicine at McMaster University, shedding light on…
By. Joanne Kotsopoulos, MD, Date: 12/07/2023 At the SABCS 2023 conference, Joanne Kotsopoulos, MD, a researcher from the Women’s College Research…
By: Virginia Kaklamani, MD Date: 12/8/2023 Virginia Kaklamani, MD, a professor of medicine in the Division of Hematology and Oncology…
By. Anjali Advani, MD Date. 12/06/2023 In this conversation on OncologyTube, viewers can explore the SWOG 18 clinical trial with…
By: Anjali Advani, MD Date: 12/06/2023 Dive into this insightful conversation with Dr. Anjali Advani, a distinguished medical oncologist and…
By. Bartosz Chmielowski, MD PhDDate: 11/22/2023In this presentation, Bartosz Chmielowski, MD PhD, discusses advancements in cancer therapy, focusing on approaches…
By. Greg Daniels, MD Date: 11/21/2023 In this discussion, Dr. Greg Daniels, a physician in the field of solid organ…
By. Joaquim Bellmunt, MD, PhD Date. 11/17/2023 At the European Society for Medical Oncology (ESMO) 2023 Congress in Madrid, Spain,…
By. Mansoor Raza Mizra, MD Date. 11/16/2023 At ESMO this year, Mansoor Raza Mizra, MD, a figure in gynecologic oncology,…
By. Funda Meric-Bernstam, MD Date. 10/11/2023 LBA34 – Trastuzumab deruxtecan (T-DXd) for pretreated patients with HER2-expressing solid tumors. Professor Funda…
By. Yennifer Chan, MD Lisa Yen, MD Courtesy: LACNETS Date. 11/09/2023 Cabozantinib in the CABINET Trial: NET…
By. Corina Dutcus, MDDate. November 02, 2023Corina Dutcus, MD, a lead investigator in the Phase 3 LEAP-014 trial for metastatic…
By. Corina Dutcus, MDDate. November 01, 2023Corina Ductus, MD, a medical doctor and the Senior Vice President of Clinical Development…
Author: Dr. Yelena Janjigian (on-camera comments) – Courtesy of ESMO.org The Matterhorn study, a significant phase three global research effort,…
By. Corina Dutcus, MDDate. October 30, 2023In this video interview, Corina Dutcus, MD, will address pivotal aspects of phase 3…
Author: Dr Michiel van der Heijden (on-camera comments) – Courtesy of ESMO.org Checkmate 901, a study focusing on first-line treatment…
Dr Laurence Albiges (on-camera comments) – Courtesy of ESMO.org During ESMO 2023, an individual presented a study at the forefront…
Pre-Roll Example
Advertising on OncologyTube For A Limited Time No Contracts! Pay As You Go! Book Now! or Contact Us for More Info…
Refresh URL Changing Content
Hi Nkem – I just wanted to reach out and introduce myself. I’m Allen Wilbanks here at OncologyTube. It seems…
Hi Maria, I’m Allen Wilbanks and I’m taking over all of Scott Nasiff’s accounts here at OncologyTube and I thought…
Hi Frances, Hope you are well. You had reached out to OncologyTube on July 4th and I sent you some…
Hi Dina, just wanted to say and let you know that we just registered for SABCS 2023 so we will…
Shira N. Dinner, MD. Associate Professor, Medicine, Hematology Oncology Division; Feinberg School of Medicine Sherra Diner, MD, an esteemed associate…
Thromboembolism are highly prevalent and burdensome in patients with cancer. Risk for venous thromboembolism (VTE) varies widely across specific cancer…
Ismael Rodriguez Rivera, MD, Medical Oncologist and Clinical Investigator from NEXT Oncology, has conducted a groundbreaking study on a novel…
iFrame is not supported! Spatial Biology: Lunaphore’s COMET Portfolio Becomes the First Complete and Inclusive Solution Déborah Heintze By Déborah…
Lunaphore, COMET™ portfolio, spatial biology, end-to-end solution, universal solution, breakthrough technology, researchers, clinicians
Diabetes Cancer: Racial Disparities In Prevention An Epidemiological Perspective By Gaole Song By Gaole Song, DrPH From the City of…
Health Inequity in Cancer Research: Examining and Uncovering the Disparities by Hala Borno MD By Hala Borno, MD What also…
iFrame is not supported! Tumor-Associated Macrophages: BDC-3042 Animal Model Dr. Kenkel SITC 2022 What are tumor-associated macrophages? Our antibody that…
Tumor-Associated Macrophages: BDC-3042 Animal Model Dr. Kenkel SITC 2022 What are tumor-associated macrophages? Our antibody that we refer to as…
Shahid Gilani, MD, Specialist doctor in Clinical Oncology from University Hospital of North Midlands, speaks about the Cancer Associated Thrombo-prophylaxis.…
PROTECTIVE-2 Phase 3 Trial [2022] Update  Is Plinabulin a new compound? Has it been used in other disease states?…
Question and Answer Session  Warren Chow, MD – ASCO [2022] Sarcomas Cancer In-Depth Slides: MOASC https://oncologytube.com/v/41319 Warren Chow, MD…
Anemia and Zinc Deficiency [2022]: MOASC Spotlight  Zachary Hanson, DO MOASC Poster on Anemia Zinc Deficiency 2022 Hi, I’m…
Paraneoplastic Glomerular Nephropathy [2022]: MOASC Â Xiaojie Zhang, MD Poster On Paraneoplastic Glomerular Nephropathy Hi, I’m Xiaojie Zhang, and I’m…
Cholangiocarcinoma: Ipilimumab and Nivolumab Combo  MOASC Poster Session 2022 (Cholangiocarcinoma Ipilimumab Nivolumab) Hello, my name is Dalia Kaakour (clinical…
This quick, comprehensive video reviews the diagnosis and treatment of cancer- and chemotherapy-induced anemia (CIA). Expert faculty, Dr. Jeffrey Gilreath…
In this dynamic case challenge format, expert faculty work through two patient cases and offer supporting data and practical experience…
In this dynamic case challenge format, expert faculty work through two patient cases and offer supporting data and practical experience…
Pembrolizumab + Adoptive Cell Therapy Melanoma with T-Cell data. Tumor-infiltrating lymphocytes, and tumor-infiltrating lymphocytes recognize tumor antigens. We looked at…
APDS or activated PI3KK delta syndrome is a relatively new disease that was only fully characterized in 2013. It is…